Healthcare & Life Sciences
Egle Therapeutics
Belgiumwww.egle-tx.com/
Egle Therapeutics is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Egle Therapeutics
Based in Belgium, Egle Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Egle Therapeutics is a biotechnology company developing precision medicines that modulate regulatory T cells to treat autoimmune diseases and cancer, with clinical-stage candidates targeting IL-2 pathways.
Explore Egle Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.